Question

What is the recovery time after stem cell therapy for Muscular Dystrophy?

Recovery depends on the actual procedure and product. A brief infusion recovery does not mean muscle has regenerated, while gene or investigational protocols may require prolonged safety monitoring. Continue established care unless the neuromuscular team changes it.

Medical review statusPending clinical sign-offLast evidence update: 2026-08-05Methodology and editorial standards
Clinical review team: Dr Kamelia Milcheva, Hematologist · Dr Vadym Uvarov, Board-Certified Physician · Hepatobiliary Surgeon · Candidate of Medical SciencesEditorial responsibility: StemCellAtlas research teamEducational information only. This page does not provide medical advice, diagnosis or a treatment recommendation.

What the evidence shows for Muscular Dystrophy

Some gene-based and pharmacological treatments are authorised for defined muscular-dystrophy subtypes and eligibility criteria, while many cell approaches remain preclinical or early clinical research. The 2025 NIH muscular-dystrophy research plan stresses subtype-specific evidence, safety, durability and post-authorisation monitoring. Evidence from one dystrophy, vector or gene product cannot validate a commercial stromal-cell or exosome offer.

Am I a candidate? → · Muscular Dystrophy: full overview → · Muscular Dystrophy cost → · Cost →

Evidence checked against ISSCR, FDA and EMA guidance. See our editorial standards. This is information, not medical advice. Educational information, not medical advice; figures indicative.

Sources & further reading

Explore all sections · Data & downloads

Compare cell-therapy evidence, registered studies and published price observations.

StemCellAtlas is a source-first research and cost-planning guide. It separates registry and regulator evidence from heterogeneous commercial observations.

Request written information